1. GPCR/G Protein Neuronal Signaling
  2. Opioid Receptor
  3. (±)-U-50488

(±)-U-50488  (Synonyms: (±)-trans-(1R,2R)-U-50488)

製品番号: HY-130696A
取扱説明書 Technical Support

(±)-U-50488 ((±)-trans-(1R,2R)-U-50488) is a selective kappa opioid receptor agonist. (±)-U-50488 can improve symptoms related to status epilepticus, but has no significant effect on spontaneous seizure episodes. (±)-U-50488 can be used for research of epilepsy.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

(±)-U-50488

(±)-U-50488 構造式

CAS 番号 : 67198-13-4

容量 在庫状況
50 mg   お問い合わせ  
100 mg   お問い合わせ  
250 mg   お問い合わせ  

* アイテムを追加する前、数量をご選択ください

This product is a controlled substance and not for sale in your territory.

Other Forms of (±)-U-50488:

Top Publications Citing Use of Products
  • 生物活性

  • 純度とドキュメンテーション

  • 参考文献

  • カスタマーレビュー

製品説明

(±)-U-50488 ((±)-trans-(1R,2R)-U-50488) is a selective kappa opioid receptor agonist. (±)-U-50488 can improve symptoms related to status epilepticus, but has no significant effect on spontaneous seizure episodes. (±)-U-50488 can be used for research of epilepsy[1].

IC50 & Target[1]

κ Opioid Receptor/KOR

 

Cellular Effect
Cell Line Type Value Description References
HEK293 IC50
0.3 1
Compound: U50488
Agonist activity at human kappa opioid receptor expressed in HEK293 cells assessed as inhibition of forskolin-induced cAMP production after 30 mins by HTRF assay
Agonist activity at human kappa opioid receptor expressed in HEK293 cells assessed as inhibition of forskolin-induced cAMP production after 30 mins by HTRF assay
[PMID: 25087049]
HEK-293T IC50
0.3 1
Compound: U50488
Agonist activity at recombinant human KOR expressed in HEK293T cells assessed as inhibition of forskolin-stimulated cAMP level preincubated for 15 to 20 mins followed by forskolin addition by GloSensor assay
Agonist activity at recombinant human KOR expressed in HEK293T cells assessed as inhibition of forskolin-stimulated cAMP level preincubated for 15 to 20 mins followed by forskolin addition by GloSensor assay
[PMID: 28726402]
HEK293 IC50
0.9 1
Compound: U-50488
Agonist activity at human KOR expressed in HEK293 cells assessed as inhibition of forskolin-induced adenylyl cyclase-mediated cAMP accumulation after 30 mins by HTRF assay
Agonist activity at human KOR expressed in HEK293 cells assessed as inhibition of forskolin-induced adenylyl cyclase-mediated cAMP accumulation after 30 mins by HTRF assay
[PMID: 27776274]
CHO EC50
1.4 1
Compound: U-50488H
Agonist activity at human kappa opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding
Agonist activity at human kappa opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding
[PMID: 17981041]
CHO EC50
1.8 1
Compound: U50,488H
Agonist activity at human KOR expressed in CHO cell membranes assessed as stimulation of [35S]GTPgammaS binding incubated for 1 hr by liquid scintillation counting
Agonist activity at human KOR expressed in CHO cell membranes assessed as stimulation of [35S]GTPgammaS binding incubated for 1 hr by liquid scintillation counting
[PMID: 31738550]
C6 IC50
1.99 1
Compound: U-50488H
Displacement of [3H]dynorphin from human kappa opioid receptor expressed in C6 giloma cells
Displacement of [3H]dynorphin from human kappa opioid receptor expressed in C6 giloma cells
[PMID: 19640720]
CHO IC50
6.4 × 10-10 41
Compound: U-50488
Displacement of [3H]U 69593 from human recombinant kappa-opioid receptor expressed in CHO cells measured after 60 mins by scintillation counting method
Displacement of [3H]U 69593 from human recombinant kappa-opioid receptor expressed in CHO cells measured after 60 mins by scintillation counting method
[PMID: 27876250]
CHO IC50
6.4 × 10-10 41
Compound: U 50488
Displacement of [3H]U 69593 from rat recombinant kappa-type opioid receptor expressed in CHO cells
Displacement of [3H]U 69593 from rat recombinant kappa-type opioid receptor expressed in CHO cells
[PMID: 26988801]
CHO EC50
2.9 1
Compound: U-50488H
Agonist activity at human KOPR expressed in CHO cells assessed as enhancement of [35S]GTPgammaS binding
Agonist activity at human KOPR expressed in CHO cells assessed as enhancement of [35S]GTPgammaS binding
[PMID: 19147366]
CHO EC50
3.4 1
Compound: U-50488H
Binding potency at human kappa opioid receptor expressed in CHO cells by [35S]GTPgammaS binding assay
Binding potency at human kappa opioid receptor expressed in CHO cells by [35S]GTPgammaS binding assay
[PMID: 16945525]
CHO EC50
3.4 1
Compound: U-50488H
Concentration required to enhance [35S]GTP-gamma-S, binding to human Opioid receptor kappa expressed in CHO cells
Concentration required to enhance [35S]GTP-gamma-S, binding to human Opioid receptor kappa expressed in CHO cells
[PMID: 16051487]
CHO EC50
4.2 1
Compound: U50488
Agonist activity at human kappa opioid receptor expressed in CHO cells assessed as stimulation of [33S]GTPgammaS binding after 60 mins by scintillation counting
Agonist activity at human kappa opioid receptor expressed in CHO cells assessed as stimulation of [33S]GTPgammaS binding after 60 mins by scintillation counting
[PMID: 22439881]
CHO EC50
4.5 1
Compound: U-50488H
Enhancement of [35S]GTP-gamma-S binding to human KOR expressed in CHO cells
Enhancement of [35S]GTP-gamma-S binding to human KOR expressed in CHO cells
[PMID: 16777411]
CHO EC50
5.7 1
Compound: U-50488H
Agonist activity at human KOPR expressed in CHO cells assessed as [35S]GTPgammaS binding after 60 mins by liquid scintillation counting
Agonist activity at human KOPR expressed in CHO cells assessed as [35S]GTPgammaS binding after 60 mins by liquid scintillation counting
[PMID: 22204910]
CHO EC50
6.3 1
Compound: U-50488H
Agonist activity at human kappa opioid receptor expressed in CHO cells assessed as increase of [35S]GTPgammaS binding
Agonist activity at human kappa opioid receptor expressed in CHO cells assessed as increase of [35S]GTPgammaS binding
[PMID: 20801035]
CHO EC50
7.8 1
Compound: U50,488
Agonist activity at human kappa opioid receptor expressed in CHO cell membranes incubated for 1 hr by [35S]GTPgammaS binding assay
Agonist activity at human kappa opioid receptor expressed in CHO cell membranes incubated for 1 hr by [35S]GTPgammaS binding assay
[PMID: 30996778]
CHO EC50
9.31 1
Compound: U-50488
Agonist activity at human kappa opioid receptor expressed in CHO cell membranes incubated for 60 mins by [35S]GTPgammaS binding assay
Agonist activity at human kappa opioid receptor expressed in CHO cell membranes incubated for 60 mins by [35S]GTPgammaS binding assay
[PMID: 23134120]
CHO EC50
13.3 1
Compound: U50,488
Agonist activity at human KOR expressed in CHO cell membranes incubated for 1 hr by [35S]-GTPgammaS coupling assay
Agonist activity at human KOR expressed in CHO cell membranes incubated for 1 hr by [35S]-GTPgammaS coupling assay
[PMID: 31834798]
CHO EC50
14.4 1
Compound: U-50488
Human Opioid receptor kappa 1
mediated stimulation of [35S]- GTPgammaS binding in CHO cells (Agonist potency).
Human Opioid receptor kappa 1
mediated stimulation of [35S]- GTPgammaS binding in CHO cells (Agonist potency).
[PMID: 10893307]
CHO EC50
21.7 1
Compound: U50488H
Agonist activity at mouse cloned kappa opioid receptor expressed in CHO cells after 60 mins by [35S]GTPgammaS binding assay
Agonist activity at mouse cloned kappa opioid receptor expressed in CHO cells after 60 mins by [35S]GTPgammaS binding assay
[PMID: 24103580]
CHO ED50
27 1
Compound: (-)-U50,488
Agonist activity against human recombinant opioid kappa receptor expressed in CHO cell membranes after 3 hrs by [35S]GTP-gamma-S binding assay
Agonist activity against human recombinant opioid kappa receptor expressed in CHO cell membranes after 3 hrs by [35S]GTP-gamma-S binding assay
[PMID: 25599950]
CHO EC50
30 1
Compound: (-)-U-50488
Agonist activity at human recombinant kappa opioid receptor expressed in CHO cells by [35S]GTP-gamma-S binding assay
Agonist activity at human recombinant kappa opioid receptor expressed in CHO cells by [35S]GTP-gamma-S binding assay
[PMID: 18380425]
CHO EC50
36 1
Compound: U-50488
Activity at human cloned kappa opioid receptor expressed in CHO cells by [35S]GTPgammaS binding assay
Activity at human cloned kappa opioid receptor expressed in CHO cells by [35S]GTPgammaS binding assay
[PMID: 19027293]
CHO EC50
36 1
Compound: U-50488
Activity at human kappa opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding
Activity at human kappa opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding
[PMID: 18417347]
CHO EC50
36 1
Compound: U50488
Agonist activity at human kappa opioid receptor expressed in CHO cell membrane assessed as stimulation of [35S]GTPgammaS binding after 60 mins by liquid scintillation counting
Agonist activity at human kappa opioid receptor expressed in CHO cell membrane assessed as stimulation of [35S]GTPgammaS binding after 60 mins by liquid scintillation counting
[PMID: 23434225]
CHO EC50
36 1
Compound: U-50488
Agonist activity at human kappa opioid receptor expressed in CHO cell membrane by [35S]GTP-gamma-S binding assay
Agonist activity at human kappa opioid receptor expressed in CHO cell membrane by [35S]GTP-gamma-S binding assay
[PMID: 17935988]
CHO EC50
36 1
Compound: U-50488
Agonist activity at human kappa opioid receptor expressed in CHO cells assessed as [35S]GTPgammaS binding after 60 mins by scintillation counting
Agonist activity at human kappa opioid receptor expressed in CHO cells assessed as [35S]GTPgammaS binding after 60 mins by scintillation counting
[PMID: 23142613]
CHO EC50
36 1
Compound: U-50488
Agonist activity at human kappa opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding
Agonist activity at human kappa opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding
[PMID: 19091564]
CHO EC50
36 1
Compound: U-50488
Agonist activity at human kappa opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding
Agonist activity at human kappa opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding
[PMID: 19282177]
CHO EC50
36 1
Compound: U-50488
Agonist activity at human kappa opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding
Agonist activity at human kappa opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding
[PMID: 16942039]
CHO EC50
46 1
Compound: (-)U-50488
Agonist activity at huma kappa opioid receptor expressed in CHO cells assessed as U50488-stimulated of [35S]GTP-gamma-S binding
Agonist activity at huma kappa opioid receptor expressed in CHO cells assessed as U50488-stimulated of [35S]GTP-gamma-S binding
[PMID: 17276685]
CHO EC50
46 1
Compound: U-50488
Agonist activity at human kappa opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding after 60 mins
Agonist activity at human kappa opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding after 60 mins
[PMID: 17433695]
CHO EC50
46 1
Compound: U-50488
Agonist activity at human opioid kappa receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding
Agonist activity at human opioid kappa receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding
[PMID: 17407276]
CHO EC50
80 1
Compound: U50,488
Agonist activity at human KOR expressed in CHO cell membranes after 1 hr by [35S]GTPgammaS binding assay
Agonist activity at human KOR expressed in CHO cell membranes after 1 hr by [35S]GTPgammaS binding assay
[PMID: 32435376]
HEK293 EC50
1240 1
Compound: U-50488
Increase of JNK phosphorylation in U50488 treated HEK293 cells expressing GFP tagged kappa opioid receptor
Increase of JNK phosphorylation in U50488 treated HEK293 cells expressing GFP tagged kappa opioid receptor
[PMID: 17702750]
CHO EC50
4840 1
Compound: (-)-U-50488
Agonist activity at human recombinant mu opioid receptor expressed in CHO cells by [35S]GTP-gamma-S binding assay
Agonist activity at human recombinant mu opioid receptor expressed in CHO cells by [35S]GTP-gamma-S binding assay
[PMID: 18380425]
分子量

369.33

分子式

C19H26Cl2N2O

CAS 番号
SMILES

ClC(C=C1CC(N([C@H]2[C@H](N3CCCC3)CCCC2)C)=O)=C(C=C1)Cl

輸送条件

Room temperature in continental US; may vary elsewhere.

保管条件

Please store the product under the recommended conditions in the Certificate of Analysis.

純度とドキュメンテーション
参考文献
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

質量   濃度   体積   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

一般には略語で表示されます:C1V1 = C2V2

濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

最近チェックした製品:

オンラインお問い合わせ

Your information is safe with us. * Required Fields.

製品名

 

カスタマ需要量 *

お名前 *

 

タイトル

メールアドレス *

 

電話番号 *

デパートメント

 

組纖名 *

市区町村

都道府県

国或いは地域 *

     

必ず会社名を記載ください。個人への返信は行いません。

備考

バルクお問い合わせ

Inquiry Information

製品名:
(±)-U-50488
製品番号:
HY-130696A
数量:
MCE 日本正規代理店: